Week of October 19, 2026 — curated from leading sleep research and health sources, summarized by AI.
Years after finding relief from delayed sleep-wake phase disorder, a high schooler and her classmates are working to ensure other children don't have to endure the same anxiety.
Early data on a newly unveiled therapeutic candidate demonstrates an increase in total sleep time driven by non-rapid eye movement sleep, prompting advancement toward clinical development.
Sleep Review's sleep sensor kits guide compares these bundles on included sensors, usage, warranties, and range, as well as provides information on how to request samples.
This guide compares sleep study belts on features such as dimensions, disposable versus reusable, patient range, and technology.
Two health technology companies recently signed a memorandum of understanding to explore new medical opportunities and integrate sleep data with cardiovascular risk factors.
A billing expert outlines five checks to prepare for the new unattended sleep study CPT codes launching in January, as well as alerts billers to several potential claims complications.
The newly cleared wearable provides continuous, passive blood pressure measurements without the need for an inflatable cuff or external calibration, building on its existing sleep apnea diagnostic capabilities.
The $50 price under Bridge applies only to people using the drug solely for weight loss. Anyone who has a qualifying medical condition that the FDA approved GLP-1s to treat, such obstructive sleep apnea, is instead routed back to their Medicare Part D prescription drug plan, which can require copays of hundreds of dollars a month for GLP-1s.
A newly approved histamine H3 receptor antagonist/inverse agonist offers a non-scheduled treatment option for excessive daytime sleepiness in Japanese patients.
A new publication distills insights from over 100 expert interviews to explore clinical practice, technology, and patient advocacy shifts in the sleep field.
The circadian regulator shifted sleep onset significantly earlier in adults, paving the way for a potential FDA submission for a new indication.
Outsourcing aspects of HST to a vendor can free up in-house staff time. This guide compares HST services programs on payment, devices used, scoring and interpretation options, turnaround time, patient education, patient support, and more.